Viewing StudyNCT01524926



Ignite Creation Date: 2024-05-06 @ 12:15 AM
Last Modification Date: 2024-10-26 @ 10:46 AM
Study NCT ID: NCT01524926
Status: COMPLETED
Last Update Posted: 2023-12-11
First Post: 2012-01-24

Brief Title: CREATE Cross-tumoral Phase 2 With Crizotinib
Sponsor:
Organization: European Organisation for Research and Treatment of Cancer - EORTC